Is tissue-plasminogen activator gene polymorphism a risk factor for venous thromboembolism in every population?

Journal of Thrombosis and Thrombolysis

Volumn 19, Issue 1, 2005, Pages 61-63

  Oguzulgen, I Kivilcim ^a   Ekim, Numan ^a   Erkekol, Ferda Oner ^b   Altinok, Buket ^b   Akar, Nejat ^b  

^a GAZI UNIVERSITY   (Turkey)

^b ANKARA UNIVERSITY   (Turkey)

Author keywords

Genetics; Pulmonary embolism; t PA gene; Venous thromboembolism

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RISK; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; SEX DIFFERENCE; STATISTICAL ANALYSIS; TURKEY (REPUBLIC); VENOUS THROMBOEMBOLISM;

BASE SEQUENCE; CASE-CONTROL STUDIES; DNA PRIMERS; FEMALE; FIBRINOLYSIS; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; REFERENCE VALUES; RISK FACTORS; THROMBOEMBOLISM; TISSUE PLASMINOGEN ACTIVATOR; TURKEY; VENOUS THROMBOSIS;

EID: 21844468985     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11239-005-0941-5     Document Type: Article

References (15)

1. Lane DA, Grant PJ. Role of haemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood 2000;95:1517-1532. 1:CAS:528:DC%2BD3cXhsVGgt74%3D
2. Hooper WC, El-Jamil M, Dilley A, et al. The relation between the tissue plasminogen activator Alu I/D polymorphism and venous thromboembolism during pregnancy. Thromb Res 2001;102:33-37. 10.1016/ S0049-3848(01)00220-1
3. Walker ID, Davidson JF, Hutton I, Lawrie TDV. Disordered "fibrinolytic potential" in coronary artery disease. Thromb Res 1977;10:509-520. 10.1016/0049-3848(77)90160-8
4. Ridker PM, Vaughan DE, Stampfer MJ, Manson JE, Hennekens CH. Endogenous tissue-type plasminogen activator and risk of myocardial infarction. Lancet 1993;341:1165-1168. 10.1016/0140-6736(93)90998-V
5. van der Bom JG, Knijff P, Haverkate F, et al. Tissue Plasminogen Activator and the Risk of Myocardial Infarction. The Rotterdam Study. Circulation 1997;95:2623-2627. 9193430
6. Jansson JH, Olofsson BO, Nilsson TK. Predictive value of tissue plasminogen activator mass concentration on long term mortality in patients with coronary artery disease. Circulation 1993;88:2030-2034. 1:STN:280:ByuD3sjjtl0%3D
7. Thompson SG, Kienast J, Pyke SDN, Haverkate F, van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995;332:635-641. 10.1056/ NEJM199503093321003
8. Degen SJF, Rajput B, Reich E. The human tissue-type plasminogen activator gene. J Biol Chem 1986;261:6972-6985. 1:CAS:528:DyaL28XktlKltrc%3D
9. Yang-Feng TL, Opdenakker G, Volckaert G, Francke U. Human tissue-type plasminogen activator gene located near chromosomal breakpoint in myeloproliferative disorders. Am J Human Genet 1986;39:79-87. 1:CAS:528:DyaL28XmtVCjtrw%3D
10. Ludwig M, Wohn KD, Schleuning WD, Olek K. Allelic dimorphism in the human tissue-type plasminogen activator (t-PA) gene as a result of Alu insertion/deletion event. Hum Genet 1992;88:388-392. 1:CAS:528:DyaK38XisV2ksrw%3D
11. Carter AM, Catto AJ, Grant PJ. Determinants of tPA antigen and associations with coronary artery disease and acute cerebrovascular disease. Thromb Haemost 1998;80:632-636. 1:CAS:528:DyaK1cXms1ahs7c%3D
12. Ridker PM, Baker MT, Hennekens CH, Stampfer MJ, Vaughan DE. Alu-repeat polymorphism in the gene coding for tissue-type plasminogen activator (t-PA) and risks of myocardial infarction among middle-aged men. Arterioscler Thromb Vasc Biol 1997;17:1687-1690. 1:CAS:528:DyaK2sXmslOku7Y%3D
13. Juhan-Vauge I, Valadier J, Alessi MC, et al. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis. Thromb Haemost 1987;57:67-72. 3109059
14. Schulman S, Wiman B and the Duration of Anticoagulation (DURAC) Trial Study Group. The significance of hypofibrinolysis for the risk of recurrence of venous thromboembolism. Thromb Haemost 1996;75:607-611. 1:CAS:528:DyaK28Xis1SqsrY%3D
15. Hooper WC, Lally C, Austin H, Renshaw M, Dilley A. The role of the t-PA I/D and PAI-1 4G/5G polymorphisms in African-American adults with a diagnosis of myocardial infarction or venous thromboembolism. Thromb Res 2000;99:223-230. 10.1016/S0049-3848(00)00236-X